Literature DB >> 23147540

Microscopic margins of resection influence primary gastrointestinal stromal tumor survival.

Fausto Catena1, Monica Di Battista, Luca Ansaloni, Maria Pantaleo, Pietro Fusaroli, Valerio Di Scioscio, Donatella Santini, Margherita Nannini, Maristella Saponara, Giovanni Ponti, Roberto Persiani, Paolo Delrio, Federico Coccolini, Salomone Di Saverio, Guido Biasco, Daniel Lazzareschi, Antonio Pinna.   

Abstract

BACKGROUND: Primary gastrointestinal stromal tumors (GISTs) are stromal tumors that arise from the gastrointestinal tract. Both surgical resection and molecular therapy are crucial in the treatment of these tumors. This study analyzes the outcomes of 151 patients with GIST treated at 3 institutions. These institutions comprise the GISTologist Study Group and provided follow-up data. PATIENTS AND METHODS: 151 patients with primary GIST were admitted and treated at the St. Orsola-Malpighi University Hospital in Bologna, Italy, the Catholic University Hospital in Rome, Italy, and the Modena University Hospital and National Cancer Institute in Naples, Italy, over the past 11 years. Patient data as well as tumor and therapy variables were studied to identify factors predicting survival with a focus on the microscopic margins of resection.
RESULTS: All 151 patients had primary disease without metastasis and underwent complete resection of gross disease. The 5-year disease-free survival rate was 77%. Disease-free survival was predicted by tumor size, mitotic count, and margins of resection. Recurrence of disease after resection was predominantly intra-abdominal.
CONCLUSIONS: Tumor size, mitotic count, and microscopic margins of resection predict disease-free survival in patients with primary GIST.

Entities:  

Mesh:

Year:  2012        PMID: 23147540     DOI: 10.1159/000343585

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  15 in total

1.  Microscopic positive tumor margin does not increase the rate of recurrence in endoscopic resected gastric mesenchymal tumors compared to negative tumor margin.

Authors:  Yan Zhu; Mei-Dong Xu; Chen Xu; Xiao-Cen Zhang; Shi-Yao Chen; Yun-Shi Zhong; Yi-Qun Zhang; Wei-Feng Chen; Tian-Yin Chen; Jia-Xin Xu; Li-Qing Yao; Quan-Lin Li; Ping-Hong Zhou
Journal:  Surg Endosc       Date:  2019-05-28       Impact factor: 4.584

Review 2.  Endoscopic treatment for gastrointestinal stromal tumor: Advantages and hurdles.

Authors:  Hyung Hun Kim
Journal:  World J Gastrointest Endosc       Date:  2015-03-16

3.  Retrospective analysis of prognostic factors affecting the recurrence and disease-free survival following surgical management of gastrointestinal stromal tumors.

Authors:  Kazım Şenol; Gül Dağlar Özdemir; Arif Zeki Akat; Nuri Aydın Kama
Journal:  Turk J Surg       Date:  2020-06-08

4.  EUS-guided fine-needle biopsy for gastric submucosal tumors: Does one size fit all?

Authors:  Fabio Cortellini; Silvia Carrara; Pietro Fusaroli
Journal:  Endosc Ultrasound       Date:  2022 Mar-Apr       Impact factor: 5.628

Review 5.  State of the Art in the Treatment of Gastrointestinal Stromal Tumors.

Authors:  Benjami Garlipp; Christiane J Bruns
Journal:  Gastrointest Tumors       Date:  2015-04-21

Review 6.  Gastrointestinal stromal tumors.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  Gastroenterol Clin North Am       Date:  2013-03-13       Impact factor: 3.806

Review 7.  Current treatment strategies in pediatric gastrointestinal stromal cell tumor.

Authors:  Brent A Willobee; Hallie J Quiroz; Matthew S Sussman; Chad M Thorson; Juan E Sola; Eduardo A Perez
Journal:  Transl Gastroenterol Hepatol       Date:  2018-08-08

Review 8.  Prognostic role of microscopically positive margins for primary gastrointestinal stromal tumors: a systematic review and meta-analysis.

Authors:  Xiaofei Zhi; Baofei Jiang; Junbo Yu; Oluf Dimitri Røe; Jun Qin; Qingfeng Ni; Luning Sun; Meirong Xu; Jianwei Zhu; Lilin Ma
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

9.  Image-guided surgery using near-infrared Turn-ON fluorescent nanoprobes for precise detection of tumor margins.

Authors:  Rachel Blau; Yana Epshtein; Evgeni Pisarevsky; Galia Tiram; Sahar Israeli Dangoor; Eilam Yeini; Adva Krivitsky; Anat Eldar-Boock; Dikla Ben-Shushan; Hadas Gibori; Anna Scomparin; Ori Green; Yael Ben-Nun; Emmanuelle Merquiol; Hila Doron; Galia Blum; Neta Erez; Rachel Grossman; Zvi Ram; Doron Shabat; Ronit Satchi-Fainaro
Journal:  Theranostics       Date:  2018-05-24       Impact factor: 11.556

10.  Wide Surgical Margin Improves the Outcome for Patients with Gastrointestinal Stromal Tumors (GISTs).

Authors:  Jan Åhlén; Fredrik Karlsson; Johan Wejde; Inga-Lena Nilsson; Catharina Larsson; Robert Bränström
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.